Literature DB >> 10523389

State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension.

J C Romero1, J F Reckelhoff.   

Abstract

In this review, we examine the possibility that small increments in angiotensin II are responsible for an increase in blood pressure and maintenance of hypertension through the stimulation of oxidative stress. A low dose of angiotensin II (2 to 10 ng x kg(-1) x min(-1), which does not elicit an immediate pressor response), when given for 7 to 30 days by continuous intravenous infusion, can increase mean arterial pressure by 30 to 40 mm Hg. This slow pressor response to angiotensin is accompanied by the stimulation of oxidative stress, as measured by a significant increase in levels of 8-iso-prostaglandin F(2alpha) (F(2)-isoprostane). Superoxide radicals and nitric oxide can combine chemically to form peroxynitrite, which can then oxidize arachidonic acid to form F(2)-isoprostanes. F(2)-isoprostanes exert potent vasoconstrictor and antinatriuretic effects. Furthermore, angiotensin II can stimulate endothelin production, which also has been shown to stimulate oxidative stress. In this way, a reduction in the concentration of nitric oxide (which is quenched by superoxide) along with the formation of F(2)-isoprostanes and endothelin could potentiate the vasoconstrictor effects of angiotensin II. We hypothesize that these mechanisms, which underlie the development of the slow pressor response to angiotensin II, also participate in the production of hypertension when circulating angiotensin II levels appear normal, as occurs in many cases of essential and renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523389     DOI: 10.1161/01.hyp.34.4.943

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  78 in total

1.  Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle.

Authors:  Tracy Tazzeo; John Miller; Luke J Janssen
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

2.  Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.

Authors:  Jiaur R Gayen; Kuixing Zhang; Satish P RamachandraRao; Manjula Mahata; Yuqing Chen; Hyung-Suk Kim; Robert K Naviaux; Kumar Sharma; Sushil K Mahata; Daniel T O'Connor
Journal:  Circ Cardiovasc Genet       Date:  2010-08-20

Review 3.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

4.  A functional and histopathological comparison of proximal and distal saphenous vein contractility and morphology.

Authors:  Ilhan Golbasi; Arda Tasatargil; Nazif Hikmet Aksoy; Gulay Sadan; Edibe Karasu; Cengiz Turkay; Omer Bayezid
Journal:  Tex Heart Inst J       Date:  2005

5.  Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice.

Authors:  Jie Zhang; Kiran Chandrashekar; Yan Lu; Yanhua Duan; Phillip Qu; Jin Wei; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

6.  Novel role for retinol-binding protein 4 in the regulation of blood pressure.

Authors:  Bettina J Kraus; Juliano L Sartoretto; Pazit Polak; Tetsuya Hosooka; Takashi Shiroto; Iratxe Eskurza; Seung-Ah Lee; Hongfeng Jiang; Thomas Michel; Barbara B Kahn
Journal:  FASEB J       Date:  2015-04-24       Impact factor: 5.191

Review 7.  The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Susanna De Pascalis; Antonio Muscari
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

Review 8.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

9.  Cholesterol induces renal vasoconstriction and anti-natriuresis by inhibiting nitric oxide production in anesthetized rats.

Authors:  Libor Kopkan; Md Abdul H Khan; Agnieszka Lis; Mouhamed S Awayda; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

10.  Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

Authors:  Alynne Carvalho-Galvão; Blessing Ogunlade; Jiaxi Xu; Cristiane R A Silva-Alves; Leônidas G Mendes-Júnior; Drielle D Guimarães; Josiane C Cruz; Thyago M Queiroz; Camille M Balarini; Valdir A Braga; Catalin M Filipeanu; Eric Lazartigues; Maria do Socorro de França-Silva
Journal:  Clin Sci (Lond)       Date:  2018-07-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.